Antiepileptics

Brian Spoelhof, Lynn Frendak, Lucia Rivera Lara

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects and reactions of medications are analyzed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the 2013-2014 publications on antiepileptic drugs covers brivaracetam, carbamazepine, eslicarbazepine, ethosuximide, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital and primidone, phenytoin and fosphenytoin, pregabalin, retigabine (ezogabine), rufinamide, topiramate, valproate sodium and semisodium (divalproex), vigabatrin, and zonisamide. Antiepileptic drugs often interact with other medications through multiple mechanisms including CYP P450 induction and inhibition. There is a special review on pharmacogenomics and the link between certain genetic aberrations and the propensity to develop adverse effects to antiepileptic medications, including CYP P450 metabolism. Specific genetic polymorphisms have been associated with psychiatric symptoms in patients taking levetiracetam, liver failure in patients taking valproic acid, neurologic side effects in patients taking carbamazepine, and an increased risk of severe cutaneous reactions in patients taking carbamazepine, lamotrigine, phenytoin, and phenobarbital.

Original languageEnglish (US)
Title of host publicationA worldwide yearly survey of new data in adverse drug reactions, 2015
PublisherElsevier
Pages85-106
Number of pages22
Volume37
ISBN (Print)9780444635259
DOIs
StatePublished - 2015

Publication series

NameSide Effects of Drugs Annual
Volume37
ISSN (Print)03786080

Fingerprint

etiracetam
Carbamazepine
Valproic Acid
Anticonvulsants
zonisamide
felbamate
Drug-Related Side Effects and Adverse Reactions
Phenytoin
Phenobarbital
Ethosuximide
Primidone
Pharmaceutical Preparations
Vigabatrin
Encyclopedias
Polymorphism
Aberrations
Metabolism
Liver
Pharmacogenetics
Liver Failure

Keywords

  • Adverse drug reactions
  • Antiepileptics
  • Drug-drug interactions
  • Pharmacogenomics
  • Seizure disorder
  • Teratogenicity
  • Toxicity

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Drug guides

Cite this

Spoelhof, B., Frendak, L., & Rivera Lara, L. (2015). Antiepileptics. In A worldwide yearly survey of new data in adverse drug reactions, 2015 (Vol. 37, pp. 85-106). (Side Effects of Drugs Annual; Vol. 37). Elsevier. https://doi.org/10.1016/bs.seda.2015.06.008

Antiepileptics. / Spoelhof, Brian; Frendak, Lynn; Rivera Lara, Lucia.

A worldwide yearly survey of new data in adverse drug reactions, 2015. Vol. 37 Elsevier, 2015. p. 85-106 (Side Effects of Drugs Annual; Vol. 37).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Spoelhof, B, Frendak, L & Rivera Lara, L 2015, Antiepileptics. in A worldwide yearly survey of new data in adverse drug reactions, 2015. vol. 37, Side Effects of Drugs Annual, vol. 37, Elsevier, pp. 85-106. https://doi.org/10.1016/bs.seda.2015.06.008
Spoelhof B, Frendak L, Rivera Lara L. Antiepileptics. In A worldwide yearly survey of new data in adverse drug reactions, 2015. Vol. 37. Elsevier. 2015. p. 85-106. (Side Effects of Drugs Annual). https://doi.org/10.1016/bs.seda.2015.06.008
Spoelhof, Brian ; Frendak, Lynn ; Rivera Lara, Lucia. / Antiepileptics. A worldwide yearly survey of new data in adverse drug reactions, 2015. Vol. 37 Elsevier, 2015. pp. 85-106 (Side Effects of Drugs Annual).
@inproceedings{9e1ee71c4dc645d4b03aa9ded59c8006,
title = "Antiepileptics",
abstract = "The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects and reactions of medications are analyzed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the 2013-2014 publications on antiepileptic drugs covers brivaracetam, carbamazepine, eslicarbazepine, ethosuximide, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital and primidone, phenytoin and fosphenytoin, pregabalin, retigabine (ezogabine), rufinamide, topiramate, valproate sodium and semisodium (divalproex), vigabatrin, and zonisamide. Antiepileptic drugs often interact with other medications through multiple mechanisms including CYP P450 induction and inhibition. There is a special review on pharmacogenomics and the link between certain genetic aberrations and the propensity to develop adverse effects to antiepileptic medications, including CYP P450 metabolism. Specific genetic polymorphisms have been associated with psychiatric symptoms in patients taking levetiracetam, liver failure in patients taking valproic acid, neurologic side effects in patients taking carbamazepine, and an increased risk of severe cutaneous reactions in patients taking carbamazepine, lamotrigine, phenytoin, and phenobarbital.",
keywords = "Adverse drug reactions, Antiepileptics, Drug-drug interactions, Pharmacogenomics, Seizure disorder, Teratogenicity, Toxicity",
author = "Brian Spoelhof and Lynn Frendak and {Rivera Lara}, Lucia",
year = "2015",
doi = "10.1016/bs.seda.2015.06.008",
language = "English (US)",
isbn = "9780444635259",
volume = "37",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier",
pages = "85--106",
booktitle = "A worldwide yearly survey of new data in adverse drug reactions, 2015",

}

TY - GEN

T1 - Antiepileptics

AU - Spoelhof, Brian

AU - Frendak, Lynn

AU - Rivera Lara, Lucia

PY - 2015

Y1 - 2015

N2 - The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects and reactions of medications are analyzed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the 2013-2014 publications on antiepileptic drugs covers brivaracetam, carbamazepine, eslicarbazepine, ethosuximide, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital and primidone, phenytoin and fosphenytoin, pregabalin, retigabine (ezogabine), rufinamide, topiramate, valproate sodium and semisodium (divalproex), vigabatrin, and zonisamide. Antiepileptic drugs often interact with other medications through multiple mechanisms including CYP P450 induction and inhibition. There is a special review on pharmacogenomics and the link between certain genetic aberrations and the propensity to develop adverse effects to antiepileptic medications, including CYP P450 metabolism. Specific genetic polymorphisms have been associated with psychiatric symptoms in patients taking levetiracetam, liver failure in patients taking valproic acid, neurologic side effects in patients taking carbamazepine, and an increased risk of severe cutaneous reactions in patients taking carbamazepine, lamotrigine, phenytoin, and phenobarbital.

AB - The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects and reactions of medications are analyzed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions. This review of the 2013-2014 publications on antiepileptic drugs covers brivaracetam, carbamazepine, eslicarbazepine, ethosuximide, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital and primidone, phenytoin and fosphenytoin, pregabalin, retigabine (ezogabine), rufinamide, topiramate, valproate sodium and semisodium (divalproex), vigabatrin, and zonisamide. Antiepileptic drugs often interact with other medications through multiple mechanisms including CYP P450 induction and inhibition. There is a special review on pharmacogenomics and the link between certain genetic aberrations and the propensity to develop adverse effects to antiepileptic medications, including CYP P450 metabolism. Specific genetic polymorphisms have been associated with psychiatric symptoms in patients taking levetiracetam, liver failure in patients taking valproic acid, neurologic side effects in patients taking carbamazepine, and an increased risk of severe cutaneous reactions in patients taking carbamazepine, lamotrigine, phenytoin, and phenobarbital.

KW - Adverse drug reactions

KW - Antiepileptics

KW - Drug-drug interactions

KW - Pharmacogenomics

KW - Seizure disorder

KW - Teratogenicity

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=84938267420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938267420&partnerID=8YFLogxK

U2 - 10.1016/bs.seda.2015.06.008

DO - 10.1016/bs.seda.2015.06.008

M3 - Conference contribution

AN - SCOPUS:84938267420

SN - 9780444635259

VL - 37

T3 - Side Effects of Drugs Annual

SP - 85

EP - 106

BT - A worldwide yearly survey of new data in adverse drug reactions, 2015

PB - Elsevier

ER -